Logo image of SAFX

XCF GLOBAL INC-A (SAFX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SAFX - US98400U1034 - Common Stock

0.162 USD
-0.02 (-9.14%)
Last: 1/9/2026, 3:49:36 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SAFX. SAFX was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of SAFX have multiple concerns. SAFX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SAFX was profitable.
SAFX had a negative operating cash flow in the past year.
SAFX Yearly Net Income VS EBIT VS OCF VS FCFSAFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

SAFX has a better Return On Assets (21.81%) than 96.15% of its industry peers.
SAFX has a better Return On Equity (1708.79%) than 99.52% of its industry peers.
Industry RankSector Rank
ROA 21.81%
ROE 1708.79%
ROIC N/A
ROA(3y)2.26%
ROA(5y)N/A
ROE(3y)-14.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SAFX Yearly ROA, ROE, ROICSAFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -20 -40

1.3 Margins

SAFX has a better Profit Margin (552.55%) than 100.00% of its industry peers.
SAFX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 552.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SAFX Yearly Profit, Operating, Gross MarginsSAFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, SAFX has about the same amount of shares outstanding.
The debt/assets ratio for SAFX has been reduced compared to a year ago.
SAFX Yearly Shares OutstandingSAFX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M
SAFX Yearly Total Debt VS Total AssetsSAFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 100M 200M 300M

2.2 Solvency

SAFX has an Altman-Z score of -0.89. This is a bad value and indicates that SAFX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.89, SAFX is not doing good in the industry: 72.60% of the companies in the same industry are doing better.
SAFX has a Debt/Equity ratio of 25.74. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SAFX (25.74) is worse than 90.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 25.74
Debt/FCF N/A
Altman-Z -0.89
ROIC/WACCN/A
WACCN/A
SAFX Yearly LT Debt VS Equity VS FCFSAFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M

2.3 Liquidity

SAFX has a Current Ratio of 0.11. This is a bad value and indicates that SAFX is not financially healthy enough and could expect problems in meeting its short term obligations.
SAFX has a Current ratio of 0.11. This is amonst the worse of the industry: SAFX underperforms 92.79% of its industry peers.
SAFX has a Quick Ratio of 0.11. This is a bad value and indicates that SAFX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.09, SAFX is doing worse than 93.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.09
SAFX Yearly Current Assets VS Current LiabilitesSAFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

0

3. Growth

3.1 Past

SAFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -267.76%.
EPS 1Y (TTM)-267.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.40, the valuation of SAFX can be described as very cheap.
100.00% of the companies in the same industry are more expensive than SAFX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.00. SAFX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.41
Fwd PE N/A
SAFX Price Earnings VS Forward Price EarningsSAFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAFX Per share dataSAFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SAFX!.
Industry RankSector Rank
Dividend Yield 0%

XCF GLOBAL INC-A

NASDAQ:SAFX (1/9/2026, 3:49:36 PM)

0.162

-0.02 (-9.14%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-14 2025-11-14
Earnings (Next)N/A N/A
Inst Owners3%
Inst Owner Change0%
Ins Owners4.43%
Ins Owner ChangeN/A
Market Cap33.75M
Revenue(TTM)16.13M
Net Income(TTM)89.12M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.41
Fwd PE N/A
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 6.47
P/tB 6.47
EV/EBITDA N/A
EPS(TTM)0.4
EY246.91%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.08
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.47
Profitability
Industry RankSector Rank
ROA 21.81%
ROE 1708.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 552.55%
GM N/A
FCFM N/A
ROA(3y)2.26%
ROA(5y)N/A
ROE(3y)-14.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 25.74
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.09
Altman-Z -0.89
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-267.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-206.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2400.73%
OCF growth 3YN/A
OCF growth 5YN/A

XCF GLOBAL INC-A / SAFX FAQ

What is the fundamental rating for SAFX stock?

ChartMill assigns a fundamental rating of 1 / 10 to SAFX.


Can you provide the valuation status for XCF GLOBAL INC-A?

ChartMill assigns a valuation rating of 2 / 10 to XCF GLOBAL INC-A (SAFX). This can be considered as Overvalued.


How profitable is XCF GLOBAL INC-A (SAFX) stock?

XCF GLOBAL INC-A (SAFX) has a profitability rating of 3 / 10.


Can you provide the financial health for SAFX stock?

The financial health rating of XCF GLOBAL INC-A (SAFX) is 1 / 10.